最高の Anna Rehbein ポッドキャスト (2024)

1
Global Burden of Neurologic Conditions 2:53

3d ago2:53

2:53

Dr. Farrah Mateen and Dr. Katrin Seeher discuss the significant global burden of neurologic conditions, which affects over 3.4 billion people worldwide, and the strategies the WHO is implementing to improve care and awareness. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00038-3/fulltext#seccestitle10…

1
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 1 2:11

4d ago2:11

2:11

Drs. Jeff Ratliff, Nanditha Rajamani, and Andy Horn discuss what this study taught us about the use of deep brain stimulation when taking into account certain white matter tracts associated with key clinical Parkinson motor symptoms. Show reference: https://www.nature.com/articles/s41467-024-48731-1American Academy of Neurology による

1
Lab Minute - IgG4 3:25

5d ago3:25

3:25

Dr. Stacey Clardy discusses the importance of iron and ferritin in neurology in this lab minute. Show reference: https://ard.bmj.com/content/74/1/14aAmerican Academy of Neurology による

1
What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy 2:32

6d ago2:32

2:32

Dr. Rae Bacharach discusses the Neurology Today article, "What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy" by Gina Shaw, available in the September 19th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/what_neurologists_should_know_about.2…

1
The Topic of Neurological Care for Transgender Patients - Part 3 5:30

7d ago5:30

5:30

In the final part of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the management of epilepsy in transgender or gender diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332American Academy of Neurology による

1
Relapsing-Remitting Immunotherapy Responsive SFN 4:21

10d ago4:21

4:21

Dr. Shuvro Roy and Dr. Anne Louise Oaklander discuss the big-picture takeaways for clinicians in the context of managing small-fiber neuropathy. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200286American Academy of Neurology による

1
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society 2:25

11d ago2:25

2:25

Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746American Academy of Neurology による

1
The Topic of Neurological Care for Transgender Patients - Part 2 4:22

12d ago4:22

4:22

In part two of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss cerebrovascular risk and management in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332American Academy of Neurology による

1
The Topic of Neurological Care for Transgender Patients - Part 1 4:19

13d ago4:19

4:19

In part one of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the crucial aspects about managing headaches in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332American Academy of Neurology による

1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2 2:21

14d ago2:21

2:21

In part two of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss essential advice for general neurologists who suspect a patient might have an atypical disorder. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345American Academy of Neurology による

1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 1 3:23

17d ago3:23

3:23

In part one of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss practical tips for recognizing when a patient’s response to levodopa may indicate the need for an alternate diagnosis. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345

1
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy 1:50

18d ago1:50

1:50

Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496American Academy of Neurology による

1
Improving Clinical Documentation Efficiency with AI 2:20

19d ago2:20

2:20

Dr. Irfan Sheikh explores a newly released NeuroByte episode, providing an insightful overview of how AI technologies, including ambient intelligence, can streamline documentation processes and enhance the efficiency of clinical practices. Show references: https://learning.aan.com/courses/74256American Academy of Neurology による

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2 4:00

20d ago4:00

4:00

In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577American Academy of Neurology による

1
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene 3:09

21d ago3:09

3:09

Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/0905…

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1 4:54

24d ago4:54

4:54

In the first installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina explore the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577American Academy of Neurology による

1
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH 2:07

25d ago2:07

2:07

Dr. Amy Gelfand and Dr. Matthew Bender discuss the possible association between glymphatic outflow and extent of TSS in patients with IIH. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209529

1
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome 1:55

26d ago1:55

1:55

Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org. Show reference: https://www.neurology.org/doi/…

1
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses 2:44

27d ago2:44

2:44

Dr. Rae Bacharach discusses the Neurology Today article, "Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses" by Susan FitzGerald, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vacc…

1
Spinal Muscular Atrophy Update in Best Practices - Part 3 1:33

28d ago1:33

1:33

In the third episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the critical objective of advancing the quality of life for individuals with SMA in the coming years. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310American Academy of Neurology による

1
Specialist Physiotherapy for Functional Motor Disorder 1:42

1M ago1:42

1:42

Dr. David Perez and Dr. Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00135-2/fulltextAmerican Academy of Neurology による

1
Spinal Muscular Atrophy Update in Best Practices - Part 2 1:59

1M ago1:59

1:59

In the second episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the currently available treatments for spinal muscular atrophy. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310American Academy of Neurology による

1
Spinal Muscular Atrophy Update in Best Practice - Part 1 3:07

1M ago3:07

3:07

In the first episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the most common types of spinal muscular atrophy. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310American Academy of Neurology による

1
Blood Biomarkers to Detect Alzheimer Disease - Part 2 1:47

1M ago1:47

1:47

In part two of this series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss how this new blood test can enhance the accuracy of diagnosing Alzheimer’s disease in patients with cognitive symptoms. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669American Academy of Neurology による

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2 1:38

1M ago1:38

1:38

In the second part of this two-part series, Dr. Jeff Ratliff and Dr. Calum Hamilton discuss the clinical criteria that listeners should look out for, indicating a subtype of mild cognitive impairment known as DLB, which could potentially progress into a full dementia with Lewy body phenotype. Show reference: https://www.neurology.org/doi/10.1212/WN…

聞く価値のあるポッドキャスト

ポッドキャスト Anna Rehbein

聞く価値のあるポッドキャスト

1
Neurology Minute

American Academy of Neurology

1
Global Burden of Neurologic Conditions 2:53

1
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 1 2:11

1
Lab Minute - IgG4 3:25

1
What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy 2:32

1
The Topic of Neurological Care for Transgender Patients - Part 3 5:30

1
Relapsing-Remitting Immunotherapy Responsive SFN 4:21

1
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society 2:25

1
The Topic of Neurological Care for Transgender Patients - Part 2 4:22

1
The Topic of Neurological Care for Transgender Patients - Part 1 4:19

1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2 2:21

1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 1 3:23

1
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy 1:50

1
Improving Clinical Documentation Efficiency with AI 2:20

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2 4:00

1
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene 3:09

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1 4:54

1
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH 2:07

1
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome 1:55

1
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses 2:44

1
Spinal Muscular Atrophy Update in Best Practices - Part 3 1:33

1
Specialist Physiotherapy for Functional Motor Disorder 1:42

1
Spinal Muscular Atrophy Update in Best Practices - Part 2 1:59

1
Spinal Muscular Atrophy Update in Best Practice - Part 1 3:07

1
Blood Biomarkers to Detect Alzheimer Disease - Part 2 1:47

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2 1:38

クイックリファレンスガイド